SafeHomeDIY
  • Home
  • Health
    • Health Today
    • Women’s Health
    • Safety
    • Health & Fitness
    • Weight Loss
  • Nutrition
    • Diet
    • Food & Recipe
    • Skin Care
  • Allergies & Diseases
    • Autism
    • Remedies
  • Pets
  • News
  • #COVID-19
  • Guest Post
SafeHomeDIY
Subscribe
SafeHomeDIY
  • Home
  • Health
    • Health Today
    • Women’s Health
    • Safety
    • Health & Fitness
    • Weight Loss
  • Nutrition
    • Diet
    • Food & Recipe
    • Skin Care
  • Allergies & Diseases
    • Autism
    • Remedies
  • Pets
  • News
  • #COVID-19
  • Guest Post
  • Health
  • News

75 coronavirus patients to get experimental HIV and cancer drug this month

  • May 5, 2020
  • SafeHomeDIY

A new trial will be giving 75 coronavirus patients an experimental drug this month after two critical patients treated with it recovered.

Leronlimab is a medication by Washington-based biotechnology company CytoDyn Inc that has been developed to treat cancer and HIV.

Researchers believe the drug can quell the ‘cytokine storm’ – a deluge of immune cells that can be as damaging as the infection itself – that triggers life-threatening lung inflammation in coronavirus patients. 

The company says Phase II of its trial, which will test leronlimab against a placebo, will begin at the end of May. 

It comes not long after two COVID-19 patients in New York City were treated with the drug and went from being on ventilators in the ICU to regular hospital in a matter of days.  

A new clinical trial will test the efficacy of leronlimab, a medication in development for treating HIV and cancer, in coronavirus patients. Pictured: Health workers move a patient wearing a face mask at the at NYU Langone Hospital in New York City, May 3

A new clinical trial will test the efficacy of leronlimab, a medication in development for treating HIV and cancer, in coronavirus patients. Pictured: Health workers move a patient wearing a face mask at the at NYU Langone Hospital in New York City, May 3

A new clinical trial will test the efficacy of leronlimab, a medication in development for treating HIV and cancer, in coronavirus patients. Pictured: Health workers move a patient wearing a face mask at the at NYU Langone Hospital in New York City, May 3

In March, the drug was given to seven critically ill coronavirus patients in New York. Pictured: Vials with samples taken for coronavirus tests at Tulane University School of Medicine in New Orleans, April 2

In March, the drug was given to seven critically ill coronavirus patients in New York. Pictured: Vials with samples taken for coronavirus tests at Tulane University School of Medicine in New Orleans, April 2

In March, the drug was given to seven critically ill coronavirus patients in New York. Pictured: Vials with samples taken for coronavirus tests at Tulane University School of Medicine in New Orleans, April 2

Leronlimab is a medication that blocks CCR5, a cellular receptor that plays an important role in HIV infection, tumor growth and other diseases. 

In HIV patients, leronlimab masks CCR5, which protects healthy immune system cells from being invades by the virus. 

Among cancer patients, the drug blocking CCR5 reduced tumor growth in laboratory and animal models of breast and prostate cancer.  

Based on the results of a small initial trial, CytoDyn believes its drug has potential for treating patients severely ill with coronavirus. 

Leronlimab has only been tested in seven critically ill patients thus far, but two are now free from ventilators, and another two more show signs that the severe inflammation sending their lungs into organ failure are subsiding. 

For their earlier COVID-19 trial, doctors at a New York hospital gave the drug to seven severely ill coronavirus patients.

The drug is given via two injections – one on each side of the abdomen.

Two of them were well enough to be taken off ventilators in a matter of days, and all but one are improving, according to CytoDyn president and CEO Dr Nader Pourhassan (pictured)

Two of them were well enough to be taken off ventilators in a matter of days, and all but one are improving, according to CytoDyn president and CEO Dr Nader Pourhassan (pictured)

Two of them were well enough to be taken off ventilators in a matter of days, and all but one are improving, according to CytoDyn president and CEO Dr Nader Pourhassan (pictured)

For the first patient, a person in their 70s, improvements came almost immediately, and were considerable, from what the doctor overseeing the trial told the company’s president.

‘One of [the patients] self-extubating,’ meaning they removed their own ventilator tube, ‘and was alert an hour or two after treatment,’ CytoDyn president and CEO Dr Nader Pourhassan told DailyMail.com in an interview in March.

‘The doctor said that this patient, in the last three days before treatment, was intubated and extubated and every time they intubated him, within four to six hours they immediately had to intubate him again.’

Since the patient pulled out their own breathing tube, they’ve been doing well and has been off the ventilator.

This patient as well as the second patient treated have both now been taken off a blood pressure drug that was being used to help them cope with the distress of COVID-19 too.

Three days after the first injections of leronlimab were given, bloodwork from these and two other patients showed that the cytokine storm was subsiding.

A second dose of leronlimab was given a week after the first. All but one of the patients have so far been steadily improving.

What’s killing coronavirus patients is a complication of the virus: pneumonia.

The virus binds to lung cells, and the immune system kicks into high gear to fight the infection with every weapon it has, despite the fact that we do not have antibodies specific to COVID at the ready.

This flood of immune cells, including cytokines – the immune system’s communication system.

Cytokines tell the immune system to send a deluge of chemicals from white blood cells to attack the infection, causing inflammation.

When inflammation gets out of control and fluid starts to fill the alveoli in the lungs, a patient develops pneumonia.

In the case of many of the sickest coronavirus patients, this leads to acute respiratory distress syndrome (ARDS), a condition that requires ventilation, and even then can prove fatal.

Leronlimab interrupts this domino effect by calming the cytokine storm.

It’s not entirely clear how the drug does this, but it’s a phenomenon that CytoDyn has seen not only in its first small set of coronavirus patients but in 840 HIV patients who saw significant reductions in their levels of inflammation.

‘We are very excited about the continuing positive responses from eIND patients following their treatment with leronlimab,’ Pourhassan said in a statement. 

‘We are equally excited about the prospects for patients should the FDA grant access to leronlimab under the compassionate use program.  

‘Under the compassionate use program, we could avoid and quickly overcome…stress and turmoil which [is] very difficult for the patients, their families, the physicians, and CytoDyn.’

In the US, there are more than 1.1 million confirmed cases of the virus and more than 69,000 deaths. 

SafeHomeDIY

Health - Relationships - Lifestyle Related matters. It's All About your Safety First - It's All About You

Previous Article
  • Health
  • News

Will I ever be able to eat without bad heartburn? DR MARTIN SCURR answers your health questions

  • May 5, 2020
  • SafeHomeDIY
View Post
Next Article
  • Health
  • News

The patients fast-tracked on new drugs BEFORE they’ve been approved

  • May 5, 2020
  • SafeHomeDIY
View Post
You May Also Like
Los Angeles-based Eugenia Cooney, 29, shares fashion and make-up tips or simply chats about her life in clips watched by her two million YouTube followers. There’s another two million on TikTok, 700,000 on instagram and 440,000 on live-streaming platform Twitch
View Post
  • News

Should social media giants be allowed to profit from YouTube celebrities such as Eugenia Cooney who are clearly unwell?

  • SafeHomeDIY
  • September 23, 2023
Son's death from cancer has driven these parents to champion Hugh's law
View Post
  • News

Son's death from cancer has driven these parents to champion Hugh's law

  • SafeHomeDIY
  • September 23, 2023
Nicky Newman, pictured, who died last week following a five-year battle against breast cancer. The 35-year-old campaigner had more than 300,000 followers on Instagram, who she regularly reminded about the importance of breast health
View Post
  • News

Why are so many women under 40 being struck by breast cancer? Two of Britain's top experts, DR LIZ O'RIORDAN and DR ALICIA HEATH assess the evidence

  • SafeHomeDIY
  • September 23, 2023
Hopes raised over new Government funding for specialist clinics
View Post
  • News

Hopes raised over new Government funding for specialist clinics

  • SafeHomeDIY
  • September 23, 2023
The gadget, worn on the wrist, uses laser sensors to detect any sudden change in blood flow that would indicate heavy bleeding in the body. Post-partum haemorrhage accounts for roughly a tenth of all maternal deaths in the UK
View Post
  • News

HEALTH NOTES: New gadget can spot life-threatening bleeding after birth

  • SafeHomeDIY
  • September 23, 2023
RFK Jr. Calls the Biden Administration on the Carpet Over the Southern Border
View Post
  • News

RFK Jr. Calls the Biden Administration on the Carpet Over the Southern Border

  • SafeHomeDIY
  • September 23, 2023
Today's reader asked DR ELLIE CANNON whether her GP was wrong to refuse to test her middle aged son for prostate cancer despite a family history of the disease
View Post
  • News

DR ELLILE CANNNON: My GP is refusing to test my son for prostate cancer  – is this right?

  • SafeHomeDIY
  • September 23, 2023
Celebrities such as Lady Gaga, pictured, and Morgan Freeman suffer from the chronic pain condition fibromyalgia
View Post
  • News

Patients with fibromyalgia left in agony due to 'cruel' ban on drugs by NHS chiefs to treat the chronic pain condition whose sufferers include Lady Gaga

  • SafeHomeDIY
  • September 23, 2023
Recent Posts
  • North West, 10, debuts wild change to her appearance for bizarre new TikTok with Kim Kardashian in LA
  • Should social media giants be allowed to profit from YouTube celebrities such as Eugenia Cooney who are clearly unwell?
  • Son's death from cancer has driven these parents to champion Hugh's law
  • Where is Jesse Rugge now? His Interview Age, Family, and Wiki
  • Why are so many women under 40 being struck by breast cancer? Two of Britain's top experts, DR LIZ O'RIORDAN and DR ALICIA HEATH assess the evidence
Safe Home DIY
  • Guest Post
  • Disclaimer and Disclosure
  • Term of Use
Health - Relationships - Lifestyle Related matters. It's All About your Safety First - It's All About You

Input your search keywords and press Enter.